Recent Transactions

09-Aug-16
$NA
australia.gif
Target: 

Bionomics Limited

flag not available

Advised ASX-listed Bionomics, a clinical stage biopharmaceutical company focused on the treatment of serious central nervous system disorders and cancer, on a consultation process with shareholders following calls for Board change, leading to the formation of a shareholder working group of leading institutional investors and company-led Board renewal.

08-Aug-16
$1.5 billion
canada.gif
Target: 

Whistler Blackcomb Holdings Inc.

U.S.A. flag
Acquiror: 
Vail Resorts, Inc.

Advised Whistler Blackcomb Holdings Inc., a 75% owner and operator of the largest and most visited mountain resort in North America, on its sale to Vail Resorts, Inc.

08-Aug-16
$87 million
U.S.A. flag
Target: 

Aquasana, Inc.

U.S.A. flag
Acquiror: 
A. O. Smith Corporation

Advised A. O. Smith Corporation, a leading manufacturer of residential and commercial water heaters and boilers, on the acquisition of Aquasana, a premium water treatment company, from L Catterton

28-Jul-16
$80 million
U.S.A. flag
Target: 

BioD, LLC

U.S.A. flag
Acquiror: 
Derma Sciences, Inc.

Advised Derma Sciences, Inc., a tissue regeneration company focused on advanced wound and burn care, on the acquisition of a proprietary regenerative medicine products company BioD, LLC and a concurrent private placement.

08-Jul-16
$555 million
U.S.A. flag
Target: 

New Enterprise Stone & Lime Co., Inc.

flag not available

Advised New Enterprise Stone & Lime Co., Inc. on $555 million of secured financings, including a new $450 million senior secured term loan and substantial amendments to its existing $105 million ABL revolver

28-Jun-16
$652 million
israel.gif
Target: 

U.S. rights to 37 approved and 5 pipeline generic products

australia.gif
Acquiror: 
Mayne Pharma Group Limited

Advised Teva Pharmaceutical Industries Ltd. on the divestment of the U.S. rights  to 42 generic products

28-Jun-16
$NA
israel.gif
Target: 

U.S. rights to an authorized generic version of Adderall XR

U.S.A. flag
Acquiror: 
Prasco Laboratories

Advised Teva Pharmaceutical Industries Ltd. on the divestment of the U.S. rights  to an authorized generic version of Adderall XR

27-Jun-16
$156 million
U.S.A. flag
Target: 

ReachLocal

U.S.A. flag
Acquiror: 
Gannett

Served as independent financial advisor to the Board of Directors of Gannett in connection with its acquisition of ReachLocal

21-Jun-16
$586 million
israel.gif
Target: 

U.S. rights to a broad portfolio of 18 generic products from Teva Pharmaceutical Industries Ltd.

U.S.A. flag
Acquiror: 
Impax Laboratories, Inc.

Advised Teva Pharmaceutical Industries Ltd. on the divestment of the U.S. rights to a broad portfolio of 18 generic products to Impax Laboratories, Inc.

20-Jun-16
$NA
israel.gif
Target: 

U.S. rights to 2 generic drug products from Teva Pharmaceutical Industries Ltd.

india.gif
Acquiror: 
Zydus Cadila

Advised Teva Pharmaceutical Industries Ltd. on the divestment of the U.S. rights to 2 generic drug products to Zydus Cadila

17-Jun-16
$310 million
uk.gif
Target: 

Dobbies Garden Centres

uk.gif
Acquiror: 
Investor group led by Midlothian Capital Partners and Hattington Capital

Advised Tesco plc, a listed FTSE 100 retailer, on its sale of Dobbies Garden Centres to an investor group led by Midlothian Capital Partners and Hattington Capital

16-Jun-16
$40 million
israel.gif
Target: 

U.S. rights to 5 generic injectable drug products from Teva Pharmaceutical Industries Ltd.

U.S.A. flag
Acquiror: 
Sagent Pharmaceuticals, Inc.

Advised Teva Pharmaceutical Industries Ltd. on the divestment of the U.S. rights to 5 generic injectable drug products  to Sagent Pharmaceuticals, Inc. 

15-Jun-16
$414 million
U.S.A. flag
Target: 

Aegerion Pharmaceuticals

canada.gif
Acquiror: 
QLT Inc.

Advised QLT Inc. on its merger with Aegerion Pharmaceuticals and concurrent equity raise to create a rare disease-focused global biopharmaceutical organization

11-Jun-16
$350 million
israel.gif
Target: 

U.S. rights to 8 generic drug products from Teva Pharmaceutical Industries Ltd.

india.gif
Acquiror: 
Dr. Reddy’s Laboratories

Advised Teva Pharmaceutical Industries Ltd. on the divestment of the U.S. rights to 8 generic drug products to Dr. Reddy’s Laboratories

10-Jun-16
$NA
uk.gif
Target: 

Giraffe restaurants

uk.gif
Acquiror: 
Boparan Private Office

Advised Tesco plc, a listed FTSE 100 retailer, on its sale of the Giraffe casual dining restaurant chain to the Boparan Private Office, the private investment vehicle of the British businessman Ranjit Boparan

01-Jun-16
$221 million
australia.gif
Target: 

Patties Foods Ltd

australia.gif
Acquiror: 
Pacific Equity Partners

Advised Patties Foods Ltd (ASX:PFL), the leading Australian branded frozen food Company, with market leadership in the frozen savoury and frozen dessert segments, on its proposed sale to Pacific Equity Partners via Scheme of Arrangement

26-May-16
$500 million
Egypt, U.S. flags
Target: 

Apex International Energy Management LLC

flag not available

Advised Apex International Energy Management, a newly formed oil and gas venture focused on the Middle East and North Africa regions, in the private equity fund-raising process with multiple energy-focused financial sponsors, ultimately resulting in an initial $500 million capital commitment from Warburg Pincus.

16-May-16
$874 million
U.K., Netherlands, Germany flags
Target: 

Equinix Data Center Assets

U.S.A. flag
Acquiror: 
Digital Realty Trust

Advised Digital Realty Trust, the world's largest wholesale colocation services and data center solutions provider, on its acquisition of a portfolio of eight carrier-neutral European data centers from Equinix

10-May-16
$NA
brazil.gif
Target: 

Brasil/CT

brazil.gif
Acquiror: 
Invest Tech

Advised Brasil/CT on a capital injection made by Invest Tech in the Company.  Brasil/CT specializes in the e-commerce market and is a leader in B2C and B2B full-commerce and loyalty operations in Brazil.  Invest Tech is an investment manager focused on venture capital and private equity in the technology and telecom sectors

04-May-16
$NA
U.S.A. flag
Target: 

Portfolio of synthetic royalty and milestone rights on multiple cardiovascular programs

U.S.A. flag
Acquiror: 
Ligand Pharmaceuticals

Advised CorMatrix Cardiovascular, a leading medical device company with a differentiated extracellular matrix technology, on the sale of a portfolio of synthetic royalty and milestone rights on multiple cardiovascular programs

04-May-16
$NA
U.S.A. flag
Target: 

Affinia Group

germany.gif
Acquiror: 
MANN+HUMMEL GmbH

Advised MANN+HUMMEL GmbH, a leading global manufacturer of filtration solutions, on the acquisition of the global filtration operations (excluding the Affinia South America operations) of Affinia Group

02-May-16
$NA
U.S.A. flag
Target: 

Fairway Group Holdings Corp.

flag not available

Advised Fairway Group Holdings Corp., a grocery store chain operating fifteen stores in the New York metropolitan area, in connection with its pre-packaged Chapter 11 bankruptcy plan

28-Apr-16
$550 million
U.S.A. flag
Target: 

Broadcom’s Wireless Internet of Things (IoT) Business Unit

U.S.A. flag
Acquiror: 
Cypress Semiconductor Corporation

Advised Cypress Semiconductor, a leading provider of high-performance, mixed-signal, programmable solutions worldwide, on its acquisition of Broadcom’s Wi-Fi, Bluetooth and ZigBee product lines for automotive, industrial and consumer IoT markets

25-Apr-16
$3.4 billion
U.S.A., Euro, Brazil flags
Target: 

Divestment assets of Ball and Rexam

luxembourg.gif
Acquiror: 
Ardagh Group SA

Advised Ball Corporation on the acquisition of Rexam plc and provided a fairness opinion to the Board of Directors of Ball Corporation on the sale of select metal beverage can assets in Europe, Brazil and the United States to satisfy certain regulatory requirements in connection with its proposed acquisition of Rexam

22-Apr-16
$NA
brazil.gif
Target: 

Elavon do Brasil

brazil.gif
Acquiror: 
Stone Pagamentos

Advised Minneapolis-based U.S. Bancorp, the fifth largest commercial bank in the United States, and the parent company of Elavon, Inc., in the sale of its 50.1 percent majority stake in São Paulo-based, Elavon do Brasil to Stone Pagamentos, a local market, privately-held merchant acquirer.

Pages

show all